2 Stocks to Buy Before Earnings


Jack Adamo Image Jack Adamo Editor, Jack Adamo's Insiders Plus

Earnings may just be getting underway, but you don't have to wait to see how earnings are working out to get a hold of these two stocks that are good buys regardless, notes Jack Adamo of Insiders Plus.

We have a total of five new buys in our two portfolios (two featured below). I'm only moving on these now because they are all acting stronger than the market, and a couple are coming off bases they've been building a while. In any case, I'm enthusiastic about them all. Whether or not we hit the exact best time to buy them is of little concern.

Roche Holding (RHHBY)
This is a Swiss pharmaceutical company. Genentech is a subsidiary of it. I'll give you their PR department's official description: Roche Holding AG operates in the fields of pharmaceuticals and diagnostics worldwide. It discovers, develops, and provides diagnostic products and services that enable patients and health-care professionals in the detection, prevention, diagnosis, and treatment of diseases.

The company provides in-vitro diagnostics instruments and tests for the early detection and diagnosis of cancer. It is also involved in the research and development, and marketing of pharmaceutical products primarily in the therapeutic areas of oncology, virology, inflammation, metabolic disorders, and central nervous system.

In addition, the company provides a portfolio of diagnostics products, such as blood glucose meters for diabetes patients; point-of-care testing devices for the doctors; high-throughput analyzers for hospitals and commercial diagnostic laboratories; and state-of-the-art instruments and reagents for life science research.

Further, the company offers integrated cobas, a solution for blood serum testing in commercial and hospital labs, medical centers, and laboratory networks.